- Retrospective study of the immunogenicity and safety of the CoronaVac SARS-CoV-2 vaccine in people with underlying medical conditions | Communications Medicine Nature.com
- Scientists investigate the evolutionary origin of SARS-CoV-2 using recombination-aware phylogenetic analysis News-Medical.Net
- Mucosal IgA against SARS-CoV-2 Omicron Infection | NEJM nejm.org
- BW.1- a new Omicron subvariant that escapes immunity News-Medical.Net
- New mathematical model can predict SARS-CoV-2 incidence using wastewater-based epidemiology News-Medical.Net
- View Full coverage on Google News
Retrospective study of the immunogenicity and safety of the CoronaVac SARS-CoV-2 vaccine in people with underlying medical conditions | Communications Medicine – Nature.com
ByGoogle News
Nov 25, 2022